Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Fairness in Orphan Drug Exclusivity Act
Client: AQUESTIVE THERAPEUTICS, INC · Firm: RUBICON ADVISORS, LLC
H.R, 1629/S 250: Fairness in Orphan Drug Exclusivity Act
Fairness in Orphan Drug Exclusivity Act
Client: AQUESTIVE THERAPEUTICS, INC · Firm: RUBICON ADVISORS, LLC
H.R, 1629/S 250: Fairness in Orphan Drug Exclusivity Act
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
APOE ALZHEIMERS ALLIANCE via RUBICON ADVISORS, LLC
2026 · third_quarter · Q3
Alzheimers issues
Filing targets: Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS)
HENRY MEDS via RUBICON ADVISORS, LLC
2026 · third_quarter · Q3
Source: Senate LDA
| GILEAD SCIENCES |
| 28 |
| 2007–2012 |
| BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 27 | 2008–2014 |
| HYPOPARATHYROIDISM ASSOCIATION | 25 | 2020–2026 |
| LANNETT COMPANY, INC. | 24 | 2018–2024 |
| OFFICE OF GOVERNOR NATHAN DEAL | 24 | 2011–2016 |
| AVET PHARMACEUTICALS | 22 | 2019–2024 |
| COLLEGE OF AMERICAN PATHOLOGISTS | 19 | 2013–2017 |
| ALLIANCE TO PREVENT THE ABUSE OF MEDICINES | 18 | 2013–2017 |
| INSMED INCORPORATED | 17 | 2007–2011 |
| STATE MUTUAL INSURANCE COMPANY | 15 | 2013–2018 |
| OSMOTICA PHARMACEUTICALS | 14 | 2008–2011 |
| ALZHEON | 12 | 2024–2026 |
| IMMUNIZATION ALLIANCE FOR EQUITY AND ACCESS | 12 | 2024–2026 |
| AMERICAN SOCIETY OF INTERVENTIONAL PAIN PHYSICIANS | 11 | 2007–2009 |
| Aquestive Therapeutics, Inc. | 10 | 2021–2024 |
| CRINETICS PHARMACEUTICALS | 10 | 2023–2024 |
| ALBANY MOLECULAR RESEARCH INC. | 9 | 2016–2018 |
| HEYL CHEMISCH-PHARMAZEUTISCHE FABRIK GMBH AND CO KG | 9 | 2007–2008 |
| CHILDREN'S HOSPITAL AND RESEARCH CENTER | 8 | 2010–2011 |
| HENRY MEDS | 8 | 2025–2026 |
| APOE ALZHEIMERS ALLIANCE | 7 | 2025–2026 |
| FLEMING PHARMACEUTICALS | 7 | 2007–2008 |
| RANBAXY PHARMACEUTICALS INC | 7 | 2007–2008 |
| CIPLA USA INC | 6 | 2015–2016 |
| BIOPURE CORPORATION | 3 | 2007 |
| PURE BLUE DIAGNOSTICS, A DIVISION OF PURE BLUE MEDICAL | 3 | 2020 |
| BIOMARIN PHARMACEUTICAL INC. | 2 | 2007 |
| GLASER PEDIATRIC AIDS FOUNDATION ELIZABETH | 2 | 2007 |
| MONUMENT GROUP LLC | 1 | 2007 |
Fairness in Orphan Drug Exclusivity Act
Client: AQUESTIVE THERAPEUTICS, INC · Firm: RUBICON ADVISORS, LLC
H.R, 1629/S 250: Fairness in Orphan Drug Exclusivity Act
Fairness in Orphan Drug Exclusivity Act
Client: AQUESTIVE THERAPEUTICS, INC · Firm: RUBICON ADVISORS, LLC
H.R, 1629/S 250: Fairness in Orphan Drug Exclusivity Act
Fairness in Orphan Drug Exclusivity Act
Client: AQUESTIVE THERAPEUTICS, INC · Firm: RUBICON ADVISORS, LLC
H.R, 1629/S 250: Fairness in Orphan Drug Exclusivity Act
Fairness in Orphan Drug Exclusivity Act
Client: AQUESTIVE THERAPEUTICS, INC · Firm: RUBICON ADVISORS, LLC
H.R, 1629/S 250: Fairness in Orphan Drug Exclusivity Act
Fairness in Orphan Drug Exclusivity Act
Client: AQUESTIVE THERAPEUTICS, INC · Firm: RUBICON ADVISORS, LLC
H.R, 1629/S 250: Fairness in Orphan Drug Exclusivity Act
Fairness in Orphan Drug Exclusivity Act
Client: AQUESTIVE THERAPEUTICS, INC · Firm: RUBICON ADVISORS, LLC
H.R, 1629/S 250: Fairness in Orphan Drug Exclusivity Act
Fairness in Orphan Drug Exclusivity Act
Client: AQUESTIVE THERAPEUTICS, INC · Firm: RUBICON ADVISORS, LLC
H.R, 1629/S 250: Fairness in Orphan Drug Exclusivity Act
Fairness in Orphan Drug Exclusivity Act
Client: AQUESTIVE THERAPEUTICS, INC · Firm: RUBICON ADVISORS, LLC
H.R. 1629/S 250: Fairness in Orphan Drug Exclusivity Act
Fairness in Orphan Drug Exclusivity Act
Client: AQUESTIVE THERAPEUTICS, INC · Firm: RUBICON ADVISORS, LLC
H.R. 1629/S 250: Fairness in Orphan Drug Exclusivity Act
Restoration of America's Wire Act
Client: OFFICE OF GOVERNOR NATHAN DEAL · Firm: RUBICON ADVISORS, LLC
Pharmaceuticals HR 707, Restoration of America's Wire Act
Restoration of America's Wire Act
Client: OFFICE OF GOVERNOR NATHAN DEAL · Firm: RUBICON ADVISORS, LLC
Pharmaceuticals HR 707, Restoration of America's Wire Act
Restoration of America's Wire Act
Client: OFFICE OF GOVERNOR NATHAN DEAL · Firm: RUBICON ADVISORS, LLC
Pharmaceuticals HR 707, Restoration of America's Wire Act
Restoration of America's Wire Act
Client: OFFICE OF GOVERNOR NATHAN DEAL · Firm: RUBICON ADVISORS, LLC
HR 707, Restoring America's Wire Act
Restoration of America's Wire Act
Client: OFFICE OF GOVERNOR NATHAN DEAL · Firm: RUBICON ADVISORS, LLC
HR 707, Restoring America's Wire Act
Restoration of America's Wire Act
Client: OFFICE OF GOVERNOR NATHAN DEAL · Firm: RUBICON ADVISORS, LLC
HR 707, Restoring America's Wire Act
Restoration of America's Wire Act
Client: OFFICE OF GOVERNOR NATHAN DEAL · Firm: RUBICON ADVISORS, LLC
Pharmaceuticals HR 707, Restoration of America's Wire Act
Restoration of America's Wire Act
Client: OFFICE OF GOVERNOR NATHAN DEAL · Firm: RUBICON ADVISORS, LLC
Pharmaceuticals HR 707, Restoration of America's Wire Act
Restoration of America's Wire Act
Client: OFFICE OF GOVERNOR NATHAN DEAL · Firm: RUBICON ADVISORS, LLC
HR 707, Restoring America's Wire Act
Restoration of America's Wire Act
Client: OFFICE OF GOVERNOR NATHAN DEAL · Firm: RUBICON ADVISORS, LLC
Pharmaceuticals HR 707, Restoration of America's Wire Act
Air Traffic Control Tower Funding Restoration Act
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Air Traffic Control Tower Funding Restoration Act
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Air Traffic Control Tower Funding Restoration Act
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Justice Safety Valve Act of 2013
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Justice Safety Valve Act of 2013
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Justice Safety Valve Act of 2013
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
District of Columbia Government Shutdown Avoidance Act of 2013
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
District of Columbia Government Shutdown Avoidance Act of 2013
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
District of Columbia Government Shutdown Avoidance Act of 2013
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Strengthening Domestic Nuclear Security Act of 2014
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Strengthening Domestic Nuclear Security Act of 2014
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Strengthening Domestic Nuclear Security Act of 2014
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
All Year School Study Act
Client: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. · Firm: RUBICON ADVISORS, LLC
Physician Payment Sunshine Act S 2029 Patent Settlements H.R. 14328 .316 Affordable Healthcare Choices Act
All Year School Study Act
Client: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. · Firm: RUBICON ADVISORS, LLC
Physician Payment Sunshine Act S 2029 Patent Settlements H.R. 14328 .316 Affordable Healthcare Choices Act
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
All Year School Study Act
Client: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. · Firm: RUBICON ADVISORS, LLC
Physician Payment Sunshine Act S 2029 Patent Settlements H.R. 14328 .316 Affordable Healthcare Choices Act
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Air Traffic Control Tower Funding Restoration Act
Client: WATSON PHARMACEUTICALS INC · Firm: RUBICON ADVISORS, LLC
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Air Traffic Control Tower Funding Restoration Act
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Air Traffic Control Tower Funding Restoration Act
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Air Traffic Control Tower Funding Restoration Act
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Air Traffic Control Tower Funding Restoration Act
Client: WATSON PHARMACEUTICALS INC · Firm: RUBICON ADVISORS, LLC
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Air Traffic Control Tower Funding Restoration Act
Client: WATSON PHARMACEUTICALS INC · Firm: RUBICON ADVISORS, LLC
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Air Traffic Control Tower Funding Restoration Act
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Justice Safety Valve Act of 2013
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Justice Safety Valve Act of 2013
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Justice Safety Valve Act of 2013
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Justice Safety Valve Act of 2013
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Federal Reserve Independence Act
Client: WATSON PHARMACEUTICALS INC · Firm: RUBICON ADVISORS, LLC
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Federal Reserve Independence Act
Client: WATSON PHARMACEUTICALS INC · Firm: RUBICON ADVISORS, LLC
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Federal Reserve Independence Act
Client: WATSON PHARMACEUTICALS INC · Firm: RUBICON ADVISORS, LLC
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
District of Columbia Government Shutdown Avoidance Act of 2013
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
District of Columbia Government Shutdown Avoidance Act of 2013
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
District of Columbia Government Shutdown Avoidance Act of 2013
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
District of Columbia Government Shutdown Avoidance Act of 2013
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Strengthening Domestic Nuclear Security Act of 2014
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Strengthening Domestic Nuclear Security Act of 2014
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Strengthening Domestic Nuclear Security Act of 2014
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Strengthening Domestic Nuclear Security Act of 2014
Client: WATSON PHARMACEUTICALS INC · Firm: RUBICON ADVISORS, LLC
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Strengthening Domestic Nuclear Security Act of 2014
Client: WATSON PHARMACEUTICALS INC · Firm: RUBICON ADVISORS, LLC
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Strengthening Domestic Nuclear Security Act of 2014
Client: WATSON PHARMACEUTICALS INC · Firm: RUBICON ADVISORS, LLC
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Strengthening Domestic Nuclear Security Act of 2014
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Behavioral Health Information Technology Coordination Act of 2013
Client: WATSON PHARMACEUTICALS INC · Firm: RUBICON ADVISORS, LLC
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Behavioral Health Information Technology Coordination Act of 2013
Client: WATSON PHARMACEUTICALS INC · Firm: RUBICON ADVISORS, LLC
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Behavioral Health Information Technology Coordination Act of 2013
Client: WATSON PHARMACEUTICALS INC · Firm: RUBICON ADVISORS, LLC
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
All Year School Study Act
Client: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. · Firm: RUBICON ADVISORS, LLC
Physician Payment Sunshine Act S 2029 Patent Settlements H.R. 14328 .316 Affordable Healthcare Choices Act
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
All Year School Study Act
Client: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. · Firm: RUBICON ADVISORS, LLC
Physician Payment Sunshine Act S 2029 Patent Settlements H.R. 14328 .316 Affordable Healthcare Choices Act
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
All Year School Study Act
Client: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. · Firm: RUBICON ADVISORS, LLC
Physician Payment Sunshine Act S 2029 Patent Settlements H.R. 14328 .316 Affordable Healthcare Choices Act
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
All Year School Study Act
Client: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. · Firm: RUBICON ADVISORS, LLC
Physician Payment Sunshine Act S 2029 Patent Settlements H.R. 14328 .316 Affordable Healthcare Choices Act
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Postal Service Protection Act of 2013
Client: WATSON PHARMACEUTICALS INC · Firm: RUBICON ADVISORS, LLC
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Postal Service Protection Act of 2013
Client: WATSON PHARMACEUTICALS INC · Firm: RUBICON ADVISORS, LLC
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Postal Service Protection Act of 2013
Client: WATSON PHARMACEUTICALS INC · Firm: RUBICON ADVISORS, LLC
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Creating Sunshine, Participation, and Accountability for our Nation Act
Client: WATSON PHARMACEUTICALS INC · Firm: RUBICON ADVISORS, LLC
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Creating Sunshine, Participation, and Accountability for our Nation Act
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Creating Sunshine, Participation, and Accountability for our Nation Act
Client: WATSON PHARMACEUTICALS INC · Firm: RUBICON ADVISORS, LLC
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Creating Sunshine, Participation, and Accountability for our Nation Act
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Creating Sunshine, Participation, and Accountability for our Nation Act
Client: WATSON PHARMACEUTICALS INC · Firm: RUBICON ADVISORS, LLC
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Creating Sunshine, Participation, and Accountability for our Nation Act
Client: WATSON PHARMACEUTICALS INC · Firm: RUBICON ADVISORS, LLC
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Creating Sunshine, Participation, and Accountability for our Nation Act
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Creating Sunshine, Participation, and Accountability for our Nation Act
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Broadband Conduit Deployment Act of 2011
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Telehealth Compounding, Regulatory Intelligence
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
IMMUNIZATION ALLIANCE FOR EQUITY AND ACCESS via RUBICON ADVISORS, LLC
2026 · third_quarter · Q3
Issues related to adult immunization access
Filing targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS)
ALZHEON via RUBICON ADVISORS, LLC
2026 · third_quarter · Q3
Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA)
HYPOPARATHYROIDISM ASSOCIATION via RUBICON ADVISORS, LLC
2026 · third_quarter · Q3
Orphan drugs
Filing targets: Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS)
ASCENDIS PHARMA, INC. via RUBICON ADVISORS, LLC
2026 · third_quarter · Q3
Food and Drug Administration, Orphan Drugs
Filing targets: Food & Drug Administration (FDA)
DR. REDDY'S LABORATORIES, LTD via RUBICON ADVISORS, LLC
2026 · third_quarter · Q3
Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues, Plant Biostimulant Act
Filing targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
DYNAVAX TECHNOLOGIES via RUBICON ADVISORS, LLC
2026 · third_quarter · Q3
Prescription User Fee, Biomedical Advance Research and Development Authority (BARDA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)
APOE ALZHEIMERS ALLIANCE via RUBICON ADVISORS, LLC
2026 · second_quarter · Q2
Alzheimers issues
Filing targets: Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS)
HENRY MEDS via RUBICON ADVISORS, LLC
2026 · second_quarter · Q2
Telehealth Compounding, Regulatory Intelligence
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
IMMUNIZATION ALLIANCE FOR EQUITY AND ACCESS via RUBICON ADVISORS, LLC
2026 · second_quarter · Q2
Issues related to adult immunization access
Filing targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS)
ALZHEON via RUBICON ADVISORS, LLC
2026 · second_quarter · Q2
Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA)
HYPOPARATHYROIDISM ASSOCIATION via RUBICON ADVISORS, LLC
2026 · second_quarter · Q2
Orphan drugs
Filing targets: Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS)
ASCENDIS PHARMA, INC. via RUBICON ADVISORS, LLC
2026 · second_quarter · Q2
Food and Drug Administration, Orphan Drugs
Filing targets: Food & Drug Administration (FDA)
DYNAVAX TECHNOLOGIES via RUBICON ADVISORS, LLC
2026 · second_quarter · Q2
Prescription User Fee, Biomedical Advance Research and Development Authority (BARDA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)
DR. REDDY'S LABORATORIES, LTD via RUBICON ADVISORS, LLC
2026 · second_quarter · Q2
Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues, Plant Biostimulant Act
Filing targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
APOE ALZHEIMERS ALLIANCE via RUBICON ADVISORS, LLC
2026 · first_quarter · Q1
Alzheimers issues
Filing targets: Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS)
HENRY MEDS via RUBICON ADVISORS, LLC
2026 · first_quarter · Q1
Telehealth Compounding, Regulatory Intelligence
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
IMMUNIZATION ALLIANCE FOR EQUITY AND ACCESS via RUBICON ADVISORS, LLC
2026 · first_quarter · Q1
Issues related to adult immunization access
Filing targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS)
ALZHEON via RUBICON ADVISORS, LLC
2026 · first_quarter · Q1
Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA)
HYPOPARATHYROIDISM ASSOCIATION via RUBICON ADVISORS, LLC
2026 · first_quarter · Q1
Orphan drugs
Filing targets: Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS)
ASCENDIS PHARMA, INC. via RUBICON ADVISORS, LLC
2026 · first_quarter · Q1
Food and Drug Administration, Orphan Drugs
Filing targets: Food & Drug Administration (FDA)
DR. REDDY'S LABORATORIES, LTD via RUBICON ADVISORS, LLC
2026 · first_quarter · Q1
Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues
Filing targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
DYNAVAX TECHNOLOGIES via RUBICON ADVISORS, LLC
2026 · first_quarter · Q1
Prescription User Fee, Biomedical Advance Research and Development Authority (BARDA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)
APOE ALZHEIMERS ALLIANCE via RUBICON ADVISORS, LLC
2025 · fourth_quarter · Q4
Alzheimers issues
Filing targets: Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS)
HENRY MEDS via RUBICON ADVISORS, LLC
2025 · fourth_quarter · Q4
Telehealth Compounding, Regulatory Intelligence
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
IMMUNIZATION ALLIANCE FOR EQUITY AND ACCESS via RUBICON ADVISORS, LLC
2025 · fourth_quarter · Q4
Issues related to adult immunization access
Filing targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS)
ALZHEON via RUBICON ADVISORS, LLC
2025 · fourth_quarter · Q4
Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA)
HYPOPARATHYROIDISM ASSOCIATION via RUBICON ADVISORS, LLC
2025 · fourth_quarter · Q4
Orphan drugs
Filing targets: Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS)
ASCENDIS PHARMA, INC. via RUBICON ADVISORS, LLC
2025 · fourth_quarter · Q4
Food and Drug Administration, Orphan Drugs
Filing targets: Food & Drug Administration (FDA)
DR. REDDY'S LABORATORIES, LTD via RUBICON ADVISORS, LLC
2025 · fourth_quarter · Q4
Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues
Filing targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
DYNAVAX TECHNOLOGIES via RUBICON ADVISORS, LLC
2025 · fourth_quarter · Q4
Prescription User Fee, Biomedical Advance Research and Development Authority (BARDA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)
APOE ALZHEIMERS ALLIANCE via RUBICON ADVISORS, LLC
2025 · third_quarter · 3A
Alzheimers issues
Filing targets: Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS)
HENRY MEDS via RUBICON ADVISORS, LLC
2025 · third_quarter · Q3
Telehealth Compounding, Regulatory Intelligence
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
IMMUNIZATION ALLIANCE FOR EQUITY AND ACCESS via RUBICON ADVISORS, LLC
2025 · third_quarter · Q3
Issues related to adult immunization access
Filing targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS)
ALZHEON via RUBICON ADVISORS, LLC
2025 · third_quarter · Q3
Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA)
HYPOPARATHYROIDISM ASSOCIATION via RUBICON ADVISORS, LLC
2025 · third_quarter · Q3
Orphan drugs
Filing targets: Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS)
ASCENDIS PHARMA, INC. via RUBICON ADVISORS, LLC
2025 · third_quarter · Q3
Food and Drug Administration, Orphan Drugs
Filing targets: Food & Drug Administration (FDA)
DR. REDDY'S LABORATORIES, LTD via RUBICON ADVISORS, LLC
2025 · third_quarter · Q3
Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues
Filing targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
DYNAVAX TECHNOLOGIES via RUBICON ADVISORS, LLC
2025 · third_quarter · Q3
Prescription User Fee, Biomedical Advance Research and Development Authority (BARDA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)
APOE ALZHEIMERS ALLIANCE via RUBICON ADVISORS, LLC
2025 · second_quarter · Q2
Alzheimers
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HENRY MEDS via RUBICON ADVISORS, LLC
2025 · second_quarter · Q2
Telehealth Compounding, Regulatory Intelligence
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
IMMUNIZATION ALLIANCE FOR EQUITY AND ACCESS via RUBICON ADVISORS, LLC
2025 · second_quarter · Q2
Issues related to adult immunization access
Filing targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS)
ALZHEON via RUBICON ADVISORS, LLC
2025 · second_quarter · Q2
Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA)
HYPOPARATHYROIDISM ASSOCIATION via RUBICON ADVISORS, LLC
2025 · second_quarter · Q2
Orphan drugs
Filing targets: Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS)
ASCENDIS PHARMA, INC. via RUBICON ADVISORS, LLC
2025 · second_quarter · Q2
Food and Drug Administration, Orphan Drugs
Filing targets: Food & Drug Administration (FDA)
DR. REDDY'S LABORATORIES, LTD via RUBICON ADVISORS, LLC
2025 · second_quarter · Q2
Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues
Filing targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
DYNAVAX TECHNOLOGIES via RUBICON ADVISORS, LLC
2025 · second_quarter · Q2
Prescription User Fee, Biomedical Advance Research and Development Authority (BARDA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)
HENRY MEDS via RUBICON ADVISORS, LLC
2025 · first_quarter · Q1
Telehealth Compounding, Regulatory Intelligence
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
APOE ALZHEIMERS ALLIANCE via RUBICON ADVISORS, LLC
2025 · first_quarter · RR
HHS and FDA Alzheimers Issues
DYNAVAX TECHNOLOGIES via RUBICON ADVISORS, LLC
2025 · first_quarter · Q1
Prescription User Fee, Biomedical Advance Research and Development Authority (BARDA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)
IMMUNIZATION ALLIANCE FOR EQUITY AND ACCESS via RUBICON ADVISORS, LLC
2025 · first_quarter · Q1
Issues related to adult immunization access
Filing targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS)
ALZHEON via RUBICON ADVISORS, LLC
2025 · first_quarter · Q1
Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA)
HYPOPARATHYROIDISM ASSOCIATION via RUBICON ADVISORS, LLC
2025 · first_quarter · Q1
Orphan drugs
Filing targets: Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS)
ASCENDIS PHARMA, INC. via RUBICON ADVISORS, LLC
2025 · first_quarter · Q1
Food and Drug Administration, Orphan Drugs
Filing targets: Food & Drug Administration (FDA)
DR. REDDY'S LABORATORIES, LTD via RUBICON ADVISORS, LLC
2025 · first_quarter · Q1
Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues
Filing targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
HENRY MEDS via RUBICON ADVISORS, LLC
2025 · first_quarter · RR
Telehealth compounding, Regulatory Intelligence
IMMUNIZATION ALLIANCE FOR EQUITY AND ACCESS via RUBICON ADVISORS, LLC
2024 · fourth_quarter · Q4
Issues related to adult immunization access
Filing targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS)
ALZHEON via RUBICON ADVISORS, LLC
2024 · fourth_quarter · Q4
Alzheimers disease issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA)
HYPOPARATHYROIDISM ASSOCIATION via RUBICON ADVISORS, LLC
2024 · fourth_quarter · Q4
Orphan drugs
Filing targets: Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS)
ASCENDIS PHARMA, INC. via RUBICON ADVISORS, LLC
2024 · fourth_quarter · Q4
Food and Drug Administration, Orphan Drugs
Filing targets: Food & Drug Administration (FDA)
DR. REDDY'S LABORATORIES, LTD via RUBICON ADVISORS, LLC
2024 · fourth_quarter · Q4
Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues
Filing targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
DYNAVAX TECHNOLOGIES via RUBICON ADVISORS, LLC
2024 · fourth_quarter · Q4
Prescription User Fee, Biomedical Advance Research and Development Authority (BARDA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)
CRINETICS PHARMACEUTICALS via RUBICON ADVISORS, LLC
2024 · first_quarter · 1T
Issues related to adult immunization access
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA)
CRINETICS PHARMACEUTICALS via RUBICON ADVISORS, LLC
2024 · third_quarter · Q3
Issues related to adult immunization access
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA)
IMMUNIZATION ALLIANCE FOR EQUITY AND ACCESS via RUBICON ADVISORS, LLC
2024 · third_quarter · Q3
Issues related to adult immunization access
Filing targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS)
ALZHEON via RUBICON ADVISORS, LLC
2024 · third_quarter · Q3
Alzheimers disease issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA)
HYPOPARATHYROIDISM ASSOCIATION via RUBICON ADVISORS, LLC
2024 · third_quarter · Q3
Orphan drugs
Filing targets: Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS)
ASCENDIS PHARMA, INC. via RUBICON ADVISORS, LLC
2024 · third_quarter · Q3
Food and Drug Administration, Orphan Drugs
Filing targets: Food & Drug Administration (FDA)
DR. REDDY'S LABORATORIES, LTD via RUBICON ADVISORS, LLC
2024 · third_quarter · Q3
Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues
Filing targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
DYNAVAX TECHNOLOGIES via RUBICON ADVISORS, LLC
2024 · third_quarter · Q3
Prescription User Fee, Biomedical Advance Research and Development Authority (BARDA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)
IMMUNIZATION ALLIANCE FOR EQUITY AND ACCESS via RUBICON ADVISORS, LLC
2024 · second_quarter · Q2
Issues related to adult immunization access
Filing targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS)
IMMUNIZATION ALLIANCE FOR EQUITY AND ACCESS via RUBICON ADVISORS, LLC
2024 · first_quarter · Q1
Issues related to adult immunization access
Filing targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS)
HYPOPARATHYROIDISM ASSOCIATION via RUBICON ADVISORS, LLC
2024 · second_quarter · Q2
Orphan drugs
Filing targets: Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS)
CRINETICS PHARMACEUTICALS via RUBICON ADVISORS, LLC
2024 · second_quarter · Q2
Issues related to adult immunization access
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA)
CRINETICS PHARMACEUTICALS via RUBICON ADVISORS, LLC
2024 · first_quarter · Q1
Issues related to adult immunization access
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA)
ASCENDIS PHARMA, INC. via RUBICON ADVISORS, LLC
2024 · second_quarter · 2A
Food and Drug Administration, Orphan Drugs
Filing targets: Food & Drug Administration (FDA)
ALZHEON via RUBICON ADVISORS, LLC
2024 · second_quarter · Q2
Alzheimers disease issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA)
ALZHEON via RUBICON ADVISORS, LLC
2024 · first_quarter · Q1
Alzheimers disease issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA)
IMMUNIZATION ALLIANCE FOR EQUITY AND ACCESS via RUBICON ADVISORS, LLC
2024 · first_quarter · RR
Issues related to adult immunization access
ALZHEON via RUBICON ADVISORS, LLC
2024 · first_quarter · RR
Alzheimers disease issues
LANNETT COMPANY, INC via RUBICON ADVISORS, LLC
2024 · second_quarter · 2T
Medicare and Medicaid, Generic Prescription, COVID-19 Stimulus
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
DYNAVAX TECHNOLOGIES via RUBICON ADVISORS, LLC
2024 · second_quarter · Q2
Prescription User Fee, Biomedical Advance Research and Development Authority (BARDA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)
DR. REDDY'S LABORATORIES, LTD via RUBICON ADVISORS, LLC
2024 · second_quarter · Q2
Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues
Filing targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
ASCENDIS PHARMA, INC. via RUBICON ADVISORS, LLC
2024 · second_quarter · Q2
Food and Drug Administration, Orphan Drugs
Filing targets: Food & Drug Administration (FDA)
AQUESTIVE THERAPEUTICS, INC via RUBICON ADVISORS, LLC
2024 · first_quarter · Q1
H.R, 1629/S 250: Fairness in Orphan Drug Exclusivity Act
Filing targets: Food & Drug Administration (FDA)
HYPOPARATHYROIDISM ASSOCIATION via RUBICON ADVISORS, LLC
2024 · first_quarter · Q1
Orphan drugs
Filing targets: Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS)
ASCENDIS PHARMA, INC. via RUBICON ADVISORS, LLC
2024 · first_quarter · Q1
Food and Drug Administration, Orphan Drugs
Filing targets: Food & Drug Administration (FDA)
AVET PHARMACEUTICALS via RUBICON ADVISORS, LLC
2024 · first_quarter · Q1
GENERIC DRUG PRICING,HOUSE COMMITTEE ON OVERSIGHT,GOVERNMENT REFORM, FOOD AND DRUG ADMINISTRATION AND COVID-19 DRUG SHORTAGES
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES
LANNETT COMPANY, INC via RUBICON ADVISORS, LLC
2024 · first_quarter · Q1
Medicare and Medicaid, Generic Prescription, COVID-19 Stimulus
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
DR. REDDY'S LABORATORIES, LTD via RUBICON ADVISORS, LLC
2024 · first_quarter · Q1
Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues
Filing targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
DYNAVAX TECHNOLOGIES via RUBICON ADVISORS, LLC
2024 · first_quarter · Q1
Prescription User Fee, Biomedical Advance Research and Development Authority (BARDA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)
CRINETICS PHARMACEUTICALS via RUBICON ADVISORS, LLC
2023 · fourth_quarter · Q4
Issues related to adult immunization access
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA)
CRINETICS PHARMACEUTICALS via RUBICON ADVISORS, LLC
2023 · third_quarter · Q3
Issues related to adult immunization access
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA)
CRINETICS PHARMACEUTICALS via RUBICON ADVISORS, LLC
2023 · second_quarter · 2A
Issues related to adult immunization access
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA)
CRINETICS PHARMACEUTICALS via RUBICON ADVISORS, LLC
2023 · second_quarter · Q2
Issues related to adult immunization access
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA)
CRINETICS PHARMACEUTICALS via RUBICON ADVISORS, LLC
2023 · first_quarter · Q1
Issues related to adult immunization access
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA)
AQUESTIVE THERAPEUTICS, INC via RUBICON ADVISORS, LLC
2023 · first_quarter · 1T
H.R, 1629/S 250: Fairness in Orphan Drug Exclusivity Act
Filing targets: Food & Drug Administration (FDA)
CRINETICS PHARMACEUTICALS via RUBICON ADVISORS, LLC
2023 · first_quarter · RR
Endocrine disease issues
AQUESTIVE THERAPEUTICS, INC via RUBICON ADVISORS, LLC
2023 · fourth_quarter · Q4
H.R, 1629/S 250: Fairness in Orphan Drug Exclusivity Act
Filing targets: Food & Drug Administration (FDA)